Overview

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy of paliperidone palmitate administered as a once monthly injection in patients with an acute exacerbation of schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen-Cilag Farmaceutica Ltda.
Treatments:
Paliperidone Palmitate